CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, HOXA9 (p≤0.06) and c-myb (p≤0.08) experienced a non-significant upregulation in AML, in comparison with the other groups in the CD34-ve fraction., A similar pattern of expression for the Indicator genes in the normal and CML samples, especially in the total BM fraction was found in the mean rank analysis for the comparison of AML, CML, and normal BM.